As recognition of their various functions has increased, TMDs have been found not only to support proteins across cell membranes but also to have important roles in molecular and cellular recognition processes and in protein-protein interactions
In the UK, several GLP-1 receptor agonists are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA), each with specific indications: semaglutide (Ozempic for type 2 diabetes, Wegovy for weight management), dulaglutide (Trulicity for type 2 diabetes), and liraglutide (Victoza for type 2 diabetes, Saxenda for weight management)
Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer
C.DubsJ
Ellouk-Achard S, Levresse V, Martin C, Pham-Huy C, Dutertre-Catella H, Thevenin M et al